ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
118 hedge funds and large institutions have $602M invested in Adamas Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 46 increasing their positions, 26 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $702M → $602M (-$100M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
118
Holding in Top 10
5
Calls
$7.01M
Puts
$5.86M
Top Buyers
| 1 | +$34.4M | |
| 2 | +$27.1M | |
| 3 | +$22M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$15.1M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$8.4M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$11.5M | |
| 3 | -$7.72M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.59M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.78M |